Taken together, these data provide evidence that HH/GLI cooperates with JAK/STAT signaling to synergistically activate the expression of the immunosuppressive enzyme IDO1 in melanoma and non-melanoma skin cancer patients. Here, IDO1 is linked to skin neoplasm.